Can I read EBSCO-FullText-04 30 2026 on EtoBox?
EBSCO-FullText-04 30 2026 by Rui Costa is a document available to read on EtoBox.
What is EBSCO-FullText-04 30 2026 about?
The review discusses the efficacy of romosozumab, a bone-forming agent, in the treatment of osteoporosis, emphasizing its role as a first-line therapy for high-risk fracture patients followed by sequential treatment with resorption inhibitors. It highlights the need for sequential therapy due to the limited 12-month treatment period of romosozumab and evaluates its effectiveness in combination with other osteoporosis medications based on clinical trials and real-world data. The findings indicate that while
- Author
- Rui Costa
- Language
- EN